|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | PTEN signaling pathways in melanoma 显示文摘 | Wu H Goel V Haluska FG | 2003 | Oncogene2003，22，20： | 1 |
| 2 | PTEN signaling pathways inmelanoma显示文摘 | Wu H Goel V Haluska FG | 2003 | Oncogene2003，22，20： | 1 |
| 3 | Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities显示文摘 | Jonasch E Haluska FG | 2001 | Oncologist2001，6，1： | 1 |
| 4 | PTEN signaling pathways in melanoma显示文摘 | Wu H Goel V Haluska FG | 2003 | Oncogene2003，22，20： | 1 |
| 5 | Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer gefitinib显示文摘 | Lynch TJ Bell DW Sordella R Gurubhagavatula S Okimoto RA Brannigan BW Harris PL Haserlat SM Supko JG Haluska FG Louis DN Christiani DC Settleman J Haber DA | | 0，，： | 1 |
| 6 | Genetic alterations in signaling pathways in melanoma显示文摘 | Haluska FG Tsao H Wu H | 2006 | Clin Cancer Res2006，12，： | 1 |
| 7 | Treatment of melanoma with 5- fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis throughperforin/granzyme- and Fas-mediated pathways 显示文摘 | Yang S Haluska FG | 2004 | J Immunol2004，172，4： | 1 |
| 8 | Interferon in oncological practice: review of interferon biology, clinical applications, and toxici- ties显示文摘 | Jonasch E Haluska FG | 2001 | Oncologist2001，6，1： | 1 |
| 9 | Treatment of melanoma with 5 - fluorouraeil or dacarbazine in vitro sensitizes cells to antigen - specific CTL lysis throughperforin/granzyme - and Fas - mediated pathways显示文摘 | Yang S Haluska FG | 2004 | J Immunol2004，172，： | 1 |
| 10 | Molecular genetics of familial cutaneous melanoma 显示文摘 | Haluska FG Hodi FS | 1998 | J Clin Oncol1998，16，2： | 1 |
| 11 | PTEN signaling pathways in melanoma 显示文摘 | Wu H Goel ~ Haluska FG | 2003 | Oncogene2003，22，20： | 1 |
| 12 | Treatment of melanoma with 5-fluo- rouracil or dacarbazine in vitro sensitizes cells to antigen- specific CTL lysis through perforin/granzyme- and Fas- mediated pathways 显示文摘 | Yang S Haluska FG | 2004 | J Immunol2004，172，7： | 1 |
| 13 | Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities显示文摘 | Jonasch E Haluska FG | 2001 | Oncologist2001，6，1： | 1 |
| 14 | Brief report:graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donor显示文摘 | Shivdasani RA Haluska FG Dock NL | 1993 | New Engl J Med1993，328，： | 1 |
| 15 | Treatment of melanoma with 5-fiu-orouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme-and Fas-mediated pathways 显示文摘 | Yang S Haluska FG | 2004 | J Immunol2004，172，： | 1 |
| 16 | PTEN signaling pathways in melanoma显示文摘 | Wu H Goel V Haluska FG | 2003 | Oncogene2003，22，20： | 1 |
| 17 | Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme-and Fas-mediated pathways显示文摘 | Yang S Haluska FG | 2004 | J Immunol2004，172，7： | 1 |
| 18 | Interferon in oncological practice:review of interferon biology, clinical applications, and toxicities显示文摘 | Jonasch E Haluska FG | 2001 | Oncologist2001，6，： | 1 |
| 19 | Interferon in oncological practice:review of interferon biology,clinical applications,and toxicities显示文摘 | Jonasch E Haluska FG | 2001 | Oncologist2001，6，1： | 1 |
| 20 | PTEN signaling pathways in melanoma显示文摘 | Wu H Goel V Haluska FG | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员